Ali Al‐Hakim

Contaminated Heparin Associated with Adverse Clinical Events and Activation of the Contact System

Takashi Kishimoto, Karthik Viswanathan, Tanmoy Ganguly et al. · New England Journal of Medicine · 2008 · 613 citations · Full text

Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events

Marco Guerrini, Daniela Beccati, Zachary Shriver et al. · Nature Biotechnology · 2008 · 612 citations

Chondroitin Sulfate, Adverse Clinical Events, Pharmacology +4

FDA Approval: Ado-Trastuzumab Emtansine for the Treatment of Patients with HER2-Positive Metastatic Breast Cancer

Laleh Amiri‐Kordestani, Gideon M. Blumenthal, Qiang Xu et al. · Clinical Cancer Research · 2014 · 336 citations

Metastatic Breast Cancer, Independent Review Committee, Breast Oncology +13

Radium Ra 223 Dichloride Injection: U.S. Food and Drug Administration Drug Approval Summary

Paul G. Kluetz, William F. Pierce, V. Ellen Maher et al. · Clinical Cancer Research · 2013 · 162 citations

Dichloride Injection, Cancer Management, Pharmacotherapy +17

FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia

R. Angelo de Claro, Karen M. McGinn, Nicole Verdun et al. · Clinical Cancer Research · 2015 · 156 citations

Preclinical Therapeutics, Tyrosine Kinase, Pathology +18